Naomi Shimizu

3.4k total citations
100 papers, 2.4k citations indexed

About

Naomi Shimizu is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Naomi Shimizu has authored 100 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 18 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Naomi Shimizu's work include Acute Myeloid Leukemia Research (10 papers), Immune Cell Function and Interaction (7 papers) and Peripheral Neuropathies and Disorders (6 papers). Naomi Shimizu is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Immune Cell Function and Interaction (7 papers) and Peripheral Neuropathies and Disorders (6 papers). Naomi Shimizu collaborates with scholars based in Japan, United States and United Kingdom. Naomi Shimizu's co-authors include Richard B. Ivry, Jennifer A. Mangels, Robert G. Jaeger, Shinichiro Motohashi, Masaru Taniguchi, Hideki Hanaoka, Toshinori Nakayama, William Prinzmetal, Chiaki Nakaseko and Takehiko Fujisawa and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Naomi Shimizu

90 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naomi Shimizu Japan 24 609 467 441 401 292 100 2.4k
Isabella Barajon Italy 22 672 1.1× 633 1.4× 591 1.3× 228 0.6× 177 0.6× 43 2.4k
Yasuo Hisa Japan 30 441 0.7× 383 0.8× 815 1.8× 228 0.6× 418 1.4× 199 3.0k
Ehud Hauben Israel 29 1.2k 2.0× 345 0.7× 912 2.1× 99 0.2× 296 1.0× 51 3.7k
Joseph Glessner United States 39 478 0.8× 194 0.4× 2.2k 4.9× 358 0.9× 583 2.0× 138 5.5k
Douglas E. Wright United States 18 924 1.5× 476 1.0× 935 2.1× 129 0.3× 243 0.8× 28 3.1k
Kaoru Ogawa Japan 36 314 0.5× 589 1.3× 945 2.1× 963 2.4× 819 2.8× 398 5.4k
Abdel G. Elkahloun United States 26 813 1.3× 479 1.0× 1.5k 3.3× 72 0.2× 217 0.7× 39 3.4k
Melanie Pritchard Australia 36 418 0.7× 550 1.2× 2.9k 6.7× 780 1.9× 242 0.8× 77 4.8k
Marcela V. Karpuj United States 20 726 1.2× 256 0.5× 1.3k 2.9× 159 0.4× 134 0.5× 26 2.9k
Monique Elmaleh France 27 160 0.3× 136 0.3× 474 1.1× 138 0.3× 435 1.5× 126 2.5k

Countries citing papers authored by Naomi Shimizu

Since Specialization
Citations

This map shows the geographic impact of Naomi Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Shimizu more than expected).

Fields of papers citing papers by Naomi Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Shimizu. The network helps show where Naomi Shimizu may publish in the future.

Co-authorship network of co-authors of Naomi Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Shimizu. A scholar is included among the top collaborators of Naomi Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Shimizu. Naomi Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohwada, Chikako, Keita Kirito, Akane Tanaka, et al.. (2025). Successful autologous stem cell transplantation in a case of central nervous system relapse of diffuse large B-cell lymphoma with concurrent polycythemia vera. International Journal of Hematology. 122(5). 766–770.
2.
Shimizu, Naomi, et al.. (2024). Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma. Internal Medicine. 63(20). 2767–2771.
3.
4.
Hayashi, Tomoatsu, Ai Yamada, Naomi Shimizu, et al.. (2022). CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells. Current Issues in Molecular Biology. 44(4). 1587–1596.
5.
Hayashi, Tomoatsu, Naomi Shimizu, Ai Yamada, et al.. (2022). PHOSPHATE exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer. Cancer Science. 113(6). 2034–2043. 18 indexed citations
6.
Yamaguchi, Takashi, Masahiro Ohira, Shoko Nakamura, et al.. (2021). High presepsin concentrations in bile and its marked elevation in biliary tract diseases: A retrospective analysis. Clinica Chimica Acta. 521. 278–284. 4 indexed citations
7.
Shimizu, Naomi, et al.. (2021). Ultrasound‐guided transurethral urinary bladder biopsy using an endoscopic biopsy forceps in dogs: 27 cases (2016–2019). Journal of Small Animal Practice. 62(9). 788–794. 1 indexed citations
8.
Aiba, Yosuke, Ryuji Sakakibara, Fuyuki Tateno, & Naomi Shimizu. (2021). Orthostatic hypotension possibly caused by vincristine. Neurology and Clinical Neuroscience. 9(4). 365–366.
9.
Shimizu, Naomi, Tomoya Muto, Shokichi Tsukamoto, et al.. (2018). Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia. Annals of Hematology. 97(4). 655–662. 17 indexed citations
10.
Ohwada, Chikako, Emiko Sakaida, Tomoya Muto, et al.. (2018). Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood. 131(19). 2173–2176. 23 indexed citations
11.
Shimizu, Naomi, et al.. (2018). Evaluation of urinary and serum level of chemokine (C‐C motif) ligand 2 as a potential biomarker in canine urothelial tumours. Veterinary and Comparative Oncology. 17(1). 11–20. 8 indexed citations
12.
Rios-Diaz, Arturo J., Wei Jiang, Vihas Patel, et al.. (2016). The obesity paradox in patients with severe soft tissue infections. The American Journal of Surgery. 214(3). 385–389. 26 indexed citations
13.
14.
Nakaseko, Chiaki, Meizi Jiang, Naomi Shimizu, et al.. (2013). The Soluble Form of LR11 Protein Is a Regulator of Hypoxia-induced, Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Adhesion of Immature Hematological Cells. Journal of Biological Chemistry. 288(17). 11877–11886. 19 indexed citations
15.
Shimizu, Naomi. (2009). Career formation and utilization of temporary agency workers. Japan labor review. 6(4). 72–92. 2 indexed citations
16.
Motohashi, Shinichiro, Kaoru Nagato, Naoki Kunii, et al.. (2009). A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer. The Journal of Immunology. 182(4). 2492–2501. 174 indexed citations
17.
Abe, Masayoshi, Kazuhiko Shibata, Hiroyasu Akatsu, et al.. (2001). Contribution of Anaphylatoxin C5a to Late Airway Responses After Repeated Exposure of Antigen to Allergic Rats. The Journal of Immunology. 167(8). 4651–4660. 59 indexed citations
18.
Abe, Masayoshi, Kazuhiko Shibata, Naomi Shimizu, et al.. (2000). Evaluating the Role of Inducible Nitric Oxide Synthase Using a Novel and Selective Inducible Nitric Oxide Synthase Inhibitor in Septic Lung Injury Produced by Cecal Ligation and Puncture. American Journal of Respiratory and Critical Care Medicine. 162(2). 716–722. 83 indexed citations
19.
Tanaka, Isao, et al.. (1987). [Single-agent trial with epirubicin in hematological malignancies].. PubMed. 33(2). 184–7. 1 indexed citations
20.
Shimizu, Naomi, et al.. (1978). [A case of acute myelogenous leukemia (AML) in 10 years course of thrombocytopenia (ITP) with episodes of splenectomy and of delivery (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(3). 295–303. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabella Barajon Breakdown of academic impact, for papers by Yasuo Hisa Breakdown of academic impact, for papers by Ehud Hauben Breakdown of academic impact, for papers by Joseph Glessner Breakdown of academic impact, for papers by Douglas E. Wright Breakdown of academic impact, for papers by Kaoru Ogawa Breakdown of academic impact, for papers by Abdel G. Elkahloun Breakdown of academic impact, for papers by Melanie Pritchard Breakdown of academic impact, for papers by Marcela V. Karpuj Breakdown of academic impact, for papers by Monique Elmaleh
Rankless by CCL
2026